NAV fell 23% year-over-year due to major write-downs in unlisted holdings, while a December rights issue raised over 20 MSEK to support key investments. The net result was -34.8 MSEK, and the company remains focused on technology, health, and sustainability sectors.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.